Europe — EMA
Dalmevin (Vildagliptin)
Dalmevin, containing Vildagliptin, is an oral medication used to manage type 2 diabetes. It helps control blood sugar levels by increasing insulin production.
Request sourcing
What is Vildagliptin?
Dalmevin, containing Vildagliptin, is an oral medication used to manage type 2 diabetes. It helps control blood sugar levels by increasing insulin production.
What is Vildagliptin used for?
Dalmevin is primarily used to treat type 2 diabetes. It works by stimulating the pancreas to produce more insulin, which helps regulate blood sugar levels. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise.
What are the side effects of Vildagliptin?
Common effects of Dalmevin may include headaches, dizziness, and gastrointestinal discomfort. Some users might experience nausea or vomiting. These effects vary among individuals and are not experienced by everyone.
What precautions apply to Vildagliptin?
Dalmevin should be handled with care. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Keep it out of reach of children and store it as directed.
What does Vildagliptin interact with?
Dalmevin may interact with other medications, including certain antibiotics and antifungal drugs. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.
